Pharmacy Search
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

New Challenges? New Opportunities

A message from the Chief Executive Officer
Winter 2022-23

Diagnostics As a Defining Touchpoint in the Claims Journey

Timing and accuracy of diagnostic test results can determine the course of an injured worker’s treatment plan and the claim
Winter 2022-23

The Triple Threat of Tobacco Use on Employer, Clinical, and Medication Complexity

Tobacco use as a complicating factor in workplace injury and recovery
Winter 2022-23

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

FDA Rejects MDMA for PTSD – Clinical Research to Continue for Psychedelics

The FDA requested additional trial data, with researchers eager to continue psychedelic trials.
Sep 2024

WCRI Reports on Factors Associated with High-Cost Claims

High-cost claims are defined as the top 5% of medical payments within 36 months of injury.
Sep 2024

In Person, In Print, and On Stage: Connect with Healthe at National Comp 2024!

Stop by our educational session or visit our booth for the latest issue of RxInformer magazine.
Sep 2024

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

Xeljanz Could Increase the Risk of Heart Problems and Cancer

New data from a safety trial creates concern surrounding the rheumatoid arthritis drug.
Feb 2021

COVID-19’s Impact on Opioid Prescribing Trends

A new report from IQVIA found that national MME dropped 17% from 2019 to 2020.
Jan 2021

IQVIA Reports on Telemedicine Trends and Opportunities

A new report explores how COVID-19 has impacted telemedicine, as well as opportunities for expansion.
Dec 2020
1 … 8 9 10 11 12 … 25

Whitepapers

lockenvelopephone-handsetmagnifiermenucross-circle